The mid-term congressional election is less than two months away and some observers wonder whether the event will be all about nothing.
InVivo Therapeutics Holdings Corp. reported the appointment of Steven McAllister as Chief Financial Officer.
According to a release from the company, McAllister has been serving as InVivo's Interim CFO since December of 2013.
McAllister previously served as Vice President, Finance and Administration for Biomet Spine and Bone Healing Technologies (a private equity-owned medical device company) from 2007-2013, where he was responsible for all accounting, finance, IT, facilities, and insurance operations activities in addition to the company's strategic planning initiatives. Prior to Biomet, McAllister spent eight years with Johnson & Johnson'sMedical Device and Diagnostics Group, where he served as Director of Finance for the worldwide spine business, and Director of Finance, Worldwide Operations, for Global Orthopedics.
Mark Perrin, InVivo's Chief Executive Officer, said, "Steve McAllister brings a wealth of experience in financial management. I value the contributions he has made during this transitional period and I am pleased to have him as part of the leadership team."
InVivo Therapeutics Holdings Corp. is a biomaterials company.
((Comments on this story may be sent to [email protected]))